Literature DB >> 122655

Effect of penicillamine on the kidney.

A M Davison1, A T Day, J R Golding, D Thomson.   

Abstract

Twenty patients with rheumatoid arthritis developing proteinuria when being treated with penicillamine have been studied. In 5 the proteinuria was mild and resolved rapidly. Eleven of the remaining patients have undergone renal biopsy. One was found to have amyloidosis, and in the other 10 there was evidence of an immune complex type of injury, manifested by a granular immunoglobulin deposition within glomerular capillary walls associated with subepithelial deposits, found on electron microscopy. The proteinuria associated with this was mild (mean 2.6 g per 24 h) and occurred on average some eight months after commencing therapy (range 6 weeks to 60 months).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122655      PMCID: PMC1543578     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  12 in total

1.  Wilson's disease; new oral therapy.

Authors:  J M WALSHE
Journal:  Lancet       Date:  1956-01-07       Impact factor: 79.321

2.  Degradation of IgG3 monoclonal proteins during storage and in the presence of a thiol (DL-penicillamine).

Authors:  G Virella
Journal:  Experientia       Date:  1971-01-15

3.  Focal glomerulitis due to penicillamine.

Authors:  J P Hayslett; K G Bensch; M Kashgarian; L E Rosenberg
Journal:  Lab Invest       Date:  1968-10       Impact factor: 5.662

4.  Proteinuria associated with D-penicillamine therapy of cystinuria.

Authors:  R G Luke; J D Briggs; G S Fell; A C Kennedy
Journal:  J Urol       Date:  1968-02       Impact factor: 7.450

5.  Observations on the treatment of rheumatoid disease with penicillamine.

Authors:  J R Golding; J V Wilson; A T Day
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

6.  The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment.

Authors:  A D Stephens; R W Watts
Journal:  Q J Med       Date:  1971-07

7.  Urinary fibrin-fibrinogen degradation poducts after renal homotransplantation.

Authors:  A R Clarkson; J B Morton; J D Cash
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

8.  The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.

Authors:  I A Jaffe
Journal:  Arthritis Rheum       Date:  1965-12

9.  Nephrotoxic effects of penicillamine in cystinuria.

Authors:  L E Rosenberg; J P Hayslett
Journal:  JAMA       Date:  1967-08-28       Impact factor: 56.272

10.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Clinical manifestations of Wilson disease in organs other than the liver and brain.

Authors:  Karolina Dzieżyc-Jaworska; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.

Authors:  E Sim; A W Dodds; A Goldin
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

3.  Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis.

Authors:  R N DeSilva; C J Eastmond
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

4.  Natural course of penicillamine nephropathy: a long term study of 33 patients.

Authors:  C L Hall; S Jawad; P R Harrison; J C MacKenzie; P A Bacon; P T Klouda; A G MacIver
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

Review 5.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.